Antiviral drug
Top View
- Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors
- Efficacy and Safety of Lopinavir/Ritonavir for Treatment Of
- Potential Antiviral Options Against SARS-Cov-2 Infection
- Ten Technologies to Fight Coronavirus
- Drug Class Review
- Antiviral and Related Nucleoside Drugs
- Regulatory Benefit-Risk Assessment
- Role of Lopinavir/Ritonavir in the Treatment of Covid-19: a Review of Current Evidence, Guideline Recommendations, and Perspectives
- Reverse Transcriptase Inhibitors: Potential Drug Delivery Combating COVID-19
- The Emerging Profile of Cross-Resistance Among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors
- Future of Nonnucleoside Reverse Transcriptase Inhibitors
- The Evolution of Antiviral Nucleoside Analogues a Review for Chemists
- Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning
- Perspectives for Antivirals to Limit SARS-Cov-2 Infection (COVID-19)
- A Critical Overview of Computational Approaches Employed for COVID-19 Drug Discovery Cite This: Chem
- New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-Cov-2 Infection
- Prescription of Antiviral Drugs During
- An Analytical Study of Drug Utilization, Disease Progression, and Adverse Events Among 165 COVID-19 Patients